GlassScriptPhysician profile
Tyler Gloschat
NPI 1114415437
$8,269.37
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $1,260 · 2021: $4,189 · 2022: $2,465 · 2023: $32.47 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,513.18 | 2021-2022 | |
| Southern Edge Orthopaedics, INC. | $2,460.00 | 2020-2021 | |
| Arthrex, INC. | $1,620.10 | 2021 | |
| Orthofix Medical, INC. | $135.27 | 2021-2023 | Physio-Stim |
| Linvatec Corporation | $116.39 | 2024 | Colink 2, 5ms |
| Horizon Therapeutics Plc | $115.57 | 2019 | |
| Smith+Nephew, INC. | $75.00 | 2019 | |
| Biotissue Holdings INC. | $66.58 | 2021 | |
| Zimmer Biomet Holdings, INC. | $54.04 | 2021 | |
| Globus Medical, INC. | $49.88 | 2021 | |
| Treace Medical Concepts, INC. | $27.31 | 2022 | |
| Bioventus LLC | $20.56 | 2021 | |
| Fortis Surgical, LLC | $15.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Gloschat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.